I. Virgolini
Department of Nuclear Medicine
University of Vienna
Austria
Name/email consistency: high
- New trends in peptide receptor radioligands. Virgolini, I., Traub, T., Novotny, C., Leimer, M., Füger, B., Li, S.R., Patri, P., Pangerl, T., Angelberger, P., Raderer, M., Andreae, F., Kurtaran, A., Dudczak, R. Q. J. Nucl. Med (2001)
- Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy. Virgolini, I., Patri, P., Novotny, C., Traub, T., Leimer, M., Füger, B., Li, S.R., Angelberger, P., Raderer, M., Wogritsch, S., Kurtaran, A., Kletter, K., Dudczak, R. Ann. Oncol. (2001)
- "MAURITIUS": tumour dose in patients with advanced carcinoma. Virgolini, I., Kurtaran, A., Angelberger, P., Raderer, M., Havlik, E., Smith-Jones, P. Ital. J. Gastroenterol. Hepatol (1999)
- Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829. Virgolini, I., Leimer, M., Handmaker, H., Lastoria, S., Bischof, C., Muto, P., Pangerl, T., Gludovacz, D., Peck-Radosavljevic, M., Lister-James, J., Hamilton, G., Kaserer, K., Valent, P., Dean, R. Cancer Res. (1998)